CURRENT MANAGEMENT OF NEPHROBLASTOMA AND NEUROBLASTOMA.
D000970:Antineoplastic Agents; D002648:Child; D003609:Dactinomycin; D005472:Fluorouracil; D007223:Infant; D007231:Infant, Newborn; D007680:Kidney Neoplasms; D008479:Mediastinal Neoplasms; D016685:Mitomycin; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000175:diagnosis* / Q000276:immunology* / Q000532:radiotherapy*; D009392:Nephrectomy; D009447:Neuroblastoma; D010997:Pleural Neoplasms; D012888:Skull Neoplasms; D013514:Surgical Procedures, Operative; D014116:Toxicology; D014750:Vincristine; D009396:Wilms Tumor
D000970:Antineoplastic Agents; D003609:Dactinomycin; D016685:Mitomycin; D014750:Vincristine; D005472:Fluorouracil
ACTINOMYCIN; ANTINEOPLASTIC AGENTS; CHILD; FLUOROURACIL; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; MEDIASTINAL NEOPLASMS; MITOMYCIN; NEOPLASM DIAGNOSIS; NEOPLASM IMMUNOLOGY; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; NEPHRECTOMY; NEPHROBLASTOMA; NEUROBLASTOMA; PLEURAL NEOPLASMS; SKULL NEOPLASMS; SURGERY, OPERATIVE; TOXICOLOGIC REPORT; VINCRISTINE